The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
The Ketogenic Diet Is an Effective Adjuvant to Radiation Therapy for the Treatment of Malignant Glioma
Open accessAbstract
INTRODUCTION: The ketogenic diet (KD) is a high-fat, low-carbohydrate diet that alters metabolism by increasing the level of ketone bodies in the blood. KetoCal® (KC) is a nutritionally complete, commercially available 4:1 (fat:carbohydrate+protein) ketogenic formula that is an effective non-pharmacologic treatment for the management of refractory pediatric epilepsy. Diet-induced ketosis causes changes to brain homeostasis that have potential for the treatment of other neurological diseases such as malignant gliomas. METHODS: We used an intracranial bioluminescent mouse model of malignant glioma. Following implantation animals were maintained on standard diet (SD) or KC. The mice received 2×4 Gy of whole brain radiation and tumor growth was followed by in vivo imaging. RESULTS: Animals fed KC had elevated levels of β-hydroxybutyrate (p = 0.0173) and an increased median survival of approximately 5 days relative to animals maintained on SD. KC plus radiation treatment were more than additive, and in 9 of 11 irradiated animals maintained on KC the bioluminescent signal from the tumor cells diminished below the level of detection (p<0.0001). Animals were switched to SD 101 days after implantation and no signs of tumor recurrence were seen for over 200 days. CONCLUSIONS: KC significantly enhances the anti-tumor effect of radiation. This suggests that cellular metabolic alterations induced through KC may be useful as an adjuvant to the current standard of care for the treatment of human malignant gliomas.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425
Mitochondrial Energetics and Therapeutics
Wallace, D. C., Fan, W., & Procaccio, V. (2010) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.4.110807.092314 · Cited by 730
Bonuccelli, G., Tsirigos, A., Whitaker-Menezes, D., Pavlides, S., Pestell, R. G., Chiavarina, B., Frank, P. G., Flomenberg, N., Howell, A., Martinez-Outschoorn, U. E., et al. (2010) · Cell Cycle · doi:10.4161/cc.9.17.12731 · Cited by 576
Is Akt the “Warburg kinase”?—Akt-energy metabolism interactions and oncogenesis
Robey, R. B., & Hay, N. (2009) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2008.11.010 · Cited by 540
Maschek, G., Savaraj, N., Priebe, W., Braunschweiger, P., Hamilton, K., Tidmarsh, G. F., De Young, L. R., & Lampidis, T. J. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3294 · Cited by 451
Nebeling, L. C., Miraldi, F., Shurin, S. B., & Lerner, E. (1995) · Journal of the American College of Nutrition · doi:10.1080/07315724.1995.10718495 · Cited by 311
Zhou, W., Mukherjee, P., Kiebish, M. A., Markis, W. T., Mantis, J. G., & Seyfried, T. N. (2007) · Nutrition & Metabolism · doi:10.1186/1743-7075-4-5 · Cited by 299
Role of glucose and ketone bodies in the metabolic control of experimental brain cancer
Seyfried, T. N., Sanderson, T. M., El-Abbadi, M. M., McGowan, R., & Mukherjee, P. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601269 · Cited by 267
Zuccoli, G., Marcello, N., Pisanello, A., Servadei, F., Vaccaro, S., Mukherjee, P., & Seyfried, T. N. (2010) · Nutrition & Metabolism · doi:10.1186/1743-7075-7-33 · Cited by 267
The ketogenic diet: Uses in epilepsy and other neurologic illnesses
Barañano, K. W., & Hartman, A. L. (2008) · Current Treatment Options in Neurology · doi:10.1007/s11940-008-0043-8 · Cited by 239
Maurer, G. D., Brucker, D. P., Bähr, O., Harter, P. N., Hattingen, E., Walenta, S., Mueller-Klieser, W., Steinbach, J. P., & Rieger, J. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-315 · Cited by 236
Stafford, P., Abdelwahab, M. G., Kim, D. Y., Preul, M. C., Rho, J. M., & Scheck, A. C. (2010) · Nutrition & Metabolism · doi:10.1186/1743-7075-7-74 · Cited by 224
Self-citationTargeting energy metabolism in brain cancer: review and hypothesis
Seyfried, T. N., & Mukherjee, P. (2005) · Nutrition & Metabolism · doi:10.1186/1743-7075-2-30 · Cited by 224
Radiation-induced Akt activation modulates radioresistance in human glioblastoma cells
Li, H.-F., Kim, J.-S., & Waldman, T. (2009) · Radiation Oncology · doi:10.1186/1748-717x-4-43 · Cited by 190
Dietary restriction reduces angiogenesis and growth in an orthotopic mouse brain tumour model
Mukherjee, P., El-Abbadi, M. M., Kasperzyk, J. L., Ranes, M. K., & Seyfried, T. N. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600298 · Cited by 178
Mukherjee, P., Abate, L. E., & Seyfried, T. N. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0308 · Cited by 169
A catabolic block does not sufficiently explain how 2-deoxy-d-glucose inhibits cell growth
Ralser, M., Wamelink, M. M., Struys, E. A., Joppich, C., Krobitsch, S., Jakobs, C., & Lehrach, H. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803090105 · Cited by 166
Newcomb, E. W., Demaria, S., Lukyanov, Y., Shao, Y., Schnee, T., Kawashima, N., Lan, L., Dewyngaert, J. K., Zagzag, D., McBride, W. H., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0593 · Cited by 166
Therapeutic options for recurrent malignant glioma
Niyazi, M., Siefert, A., Schwarz, S. B., Ganswindt, U., Kreth, F.-W., Tonn, J., & Belka, C. (2010) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2010.11.006 · Cited by 150
Ketone bodies inhibit the viability of human neuroblastoma cells
SKINNER, R. S., Trujillo, A., Ma, X., & Beierle, E. A. (2009) · Journal of Pediatric Surgery · doi:10.1016/j.jpedsurg.2008.10.042 · Cited by 119
Marsh, J., Mukherjee, P., & Seyfried, T. N. (2008) · Nutrition & Metabolism · doi:10.1186/1743-7075-5-33 · Cited by 92
Nebeling, L. C., & Lerner, E. (1995) · Journal of the American Dietetic Association · doi:10.1016/s0002-8223(95)00189-1 · Cited by 90
Akt signaling pathway: a target for radiosensitizing human malignant glioma
Chautard, E., Loubeau, G., Tchirkov, A., CHASSAGNE, J., Vermot‐Desroches, C., Morel, L., & Verrelle, P. (2010) · Neuro-Oncology · doi:10.1093/neuonc/nop059 · Cited by 90
Mulrooney, T. J., Marsh, J., Urits, I., Seyfried, T. N., & Mukherjee, P. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018085 · Cited by 75
Molecular Heterogeneity in Glioblastoma: Therapeutic Opportunities and Challenges
Nicholas, M. K., Lukas, R. V., Chmura, S. J., Yamini, B., Lesniak, M. S., & Pytel, P. (2011) · Seminars in Oncology · doi:10.1053/j.seminoncol.2011.01.009 · Cited by 75
Mitochondrial response to controlled nutrition in health and disease
Schiff, M., Bénit, P., Coulibaly, A., Loublier, S., El‐Khoury, R., & Rustin, P. (2011) · Nutrition Reviews · doi:10.1111/j.1753-4887.2010.00363.x · Cited by 59
Lund, T. M., Risa, Ø., Sonnewald, U., Schousboe, A., & Waagepetersen, H. S. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06115.x · Cited by 59
Does the existing standard of care increase glioblastoma energy metabolism?
Seyfried, T. N., Shelton, L. M., & Mukherjee, P. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70166-2 · Cited by 51
Yamada, M., Tomida, A., Yun, J., Cai, B., Yoshikawa, H., Taketani, Y., & Tsuruo, T. (1999) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800050945 · Cited by 43
Enhancement of radiation and chemotherapeutic drug responses by 2-deoxy-D-glucose in animal tumors
Dwarakanath, B. S. R., Gupta, S., Farooque, A., Adhikari, J. S., & Singh, S. P. (2009) · Journal of Cancer Research and Therapeutics · doi:10.4103/0973-1482.55135 · Cited by 40
Current and emerging molecular targets in glioma
Roesler, R., Brunetto, A. T., Abujamra, A. L., de Farias, C. B., Brunetto, A. L., & Schwartsmann, G. (2010) · Expert Review of Anticancer Therapy · doi:10.1586/era.10.167 · Cited by 35
The ketogenic diet changes metabolite levels in hippocampal extracellular fluid
Samala, R., Klein, J., & Borges, K. (2010) · Neurochemistry International · doi:10.1016/j.neuint.2010.10.011 · Cited by 32
[2,4-13C]β-hydroxybutyrate Metabolism in Astrocytes and C6 Glioblastoma Cells
Eloqayli, H., Melø, T. M., Haukvik, A., & Sonnewald, U. (2011) · Neurochemical Research · doi:10.1007/s11064-011-0485-3 · Cited by 24
Cited by
Fasting and cancer: molecular mechanisms and clinical application
Nencioni, A., Caffa, I., Cortellino, S., & Longo, V. D. (2018) · Nature Reviews Cancer · doi:10.1038/s41568-018-0061-0 · Cited by 518
Cancer as a metabolic disease: implications for novel therapeutics
Seyfried, T. N., Flores, R. E., Poff, A. M., & D'Agostino, D. P. (2014) · Carcinogenesis · doi:10.1093/carcin/bgt480 · Cited by 472
Ketogenic diet in the treatment of cancer – Where do we stand?
Weber, D. D., Aminzadeh-Gohari, S., Tulipan, J., Catalano, L., Feichtinger, R. G., & Kofler, B. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2019.06.026 · Cited by 464
Augustin, K., Khabbush, A., Williams, S., Eaton, S., Orford, M., Cross, J. H., Heales, S. J. R., Walker, M. C., & Williams, R. S. B. (2018) · The Lancet Neurology · doi:10.1016/s1474-4422(17)30408-8 · Cited by 440
Zhu, H., Bi, D., Zhang, Y., Kong, C., Du, J., Wu, X., Wei, Q., & Qin, H. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00831-w · Cited by 399
Metadata
- Authors
- Abdelwahab, M. G., Fenton, K. E., Preul, M. C., Rho, J. M., Lynch, A., Stafford, P., & Scheck, A. C.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-05-01
- Volume
- 7
- Issue
- 5
- Pages
- e36197
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W1965979340
- Cited by
- 288
- References
- 33
- FWCI
- 8.68
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.